These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8139010)

  • 1. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.
    Koito A; Harrowe G; Levy JA; Cheng-Mayer C
    J Virol; 1994 Apr; 68(4):2253-9. PubMed ID: 8139010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism.
    Morikita T; Maeda Y; Fujii S; Matsushita S; Obaru K; Takatsuki K
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1291-9. PubMed ID: 9339846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain.
    Wu Z; Kayman SC; Honnen W; Revesz K; Chen H; Vijh-Warrier S; Tilley SA; McKeating J; Shotton C; Pinter A
    J Virol; 1995 Apr; 69(4):2271-8. PubMed ID: 7533854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of HIV-1 envelope V3 loop cleavage in cell tropism.
    Gu R; Westervelt P; Ratner L
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1007-15. PubMed ID: 8280475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
    Foda M; Harada S; Maeda Y
    Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein.
    Cao J; Sullivan N; Desjardin E; Parolin C; Robinson J; Wyatt R; Sodroski J
    J Virol; 1997 Dec; 71(12):9808-12. PubMed ID: 9371651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of the V1/V2 region does not increase the accessibility of the V3 region of recombinant gp125.
    Sourial S; Nilsson C; Wärnmark A; Achour A; Harris RA
    Curr HIV Res; 2006 Apr; 4(2):229-37. PubMed ID: 16611061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.
    Freed EO; Martin MA
    J Virol; 1994 Apr; 68(4):2503-12. PubMed ID: 8139032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.
    Cho MW; Lee MK; Carney MC; Berson JF; Doms RW; Martin MA
    J Virol; 1998 Mar; 72(3):2509-15. PubMed ID: 9499115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The V1-V3 region of a brain-derived HIV-1 envelope glycoprotein determines macrophage tropism, low CD4 dependence, increased fusogenicity and altered sensitivity to entry inhibitors.
    Rossi F; Querido B; Nimmagadda M; Cocklin S; Navas-Martín S; Martín-García J
    Retrovirology; 2008 Oct; 5():89. PubMed ID: 18837996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
    Thali M; Furman C; Helseth E; Repke H; Sodroski J
    J Virol; 1992 Sep; 66(9):5516-24. PubMed ID: 1501286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
    Willey RL; Theodore TS; Martin MA
    J Virol; 1994 Jul; 68(7):4409-19. PubMed ID: 7515973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
    Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
    J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophages.
    Walter BL; Wehrly K; Swanstrom R; Platt E; Kabat D; Chesebro B
    J Virol; 2005 Apr; 79(8):4828-37. PubMed ID: 15795268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.
    Page KA; Stearns SM; Littman DR
    J Virol; 1992 Jan; 66(1):524-33. PubMed ID: 1727497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization epitopes of the HIV-1 primary isolate DH012.
    Zhu C; Matthews TJ; Chen CH
    Vaccine; 2003 Jul; 21(23):3301-6. PubMed ID: 12804861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions.
    Wyatt R; Sullivan N; Thali M; Repke H; Ho D; Robinson J; Posner M; Sodroski J
    J Virol; 1993 Aug; 67(8):4557-65. PubMed ID: 8331723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread.
    Toohey K; Wehrly K; Nishio J; Perryman S; Chesebro B
    Virology; 1995 Oct; 213(1):70-9. PubMed ID: 7483281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic Correlates of HIV-1 Macrophage Tropism.
    Arrildt KT; LaBranche CC; Joseph SB; Dukhovlinova EN; Graham WD; Ping LH; Schnell G; Sturdevant CB; Kincer LP; Mallewa M; Heyderman RS; Rie AV; Cohen MS; Spudich S; Price RW; Montefiori DC; Swanstrom R
    J Virol; 2015 Nov; 89(22):11294-311. PubMed ID: 26339058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
    Ly A; Stamatatos L
    J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.